Takaisin Tulosta

Atooppinen ekseema, näytönastekatsausten kirjallisuusviitteet

Lisätietoa aiheesta
Käypä hoito -toimitus
30.5.2023

Kirjallisuusviiteluettelosta löytyy koottuna Käypä hoito -suosituksen Atooppinen ekseema «Atooppinen ekseema»1 näytönastekatsauksissa arvioitu kirjallisuus.

Kirjallisuutta

  1. Adler-Cohen C, Czarnowicki T, Dreiher J ym. Climatotherapy at the Dead Sea: an effective treatment modality for atopic dermatitis with significant positive impact on quality of life. Dermatitis 2012;23:75-80 «PMID: 22653123»PubMed
  2. Agache I, Song Y, Posso M ym. Efficacy and safety of dupilumab for moderate-to-severe atopic dermatitis: A systematic review for the EAACI biologicals guidelines. Allergy 2021;76:45-58 «PMID: 32691892»PubMed
  3. Allen SJ, Jordan S, Storey M ym. Probiotics in the prevention of eczema: a randomised controlled trial. Arch Dis Child 2014;99:1014-9 «PMID: 24947281»PubMed
  4. Ashcroft DM, Chen LC, Garside R ym. Topical pimecrolimus for eczema. Cochrane Database Syst Rev 2007;2007:CD005500 «PMID: 17943859»PubMed
  5. Ashcroft DM, Dimmock P, Garside R ym. Efficacy and tolerability of topical pimecrolimus and tacrolimus in the treatment of atopic dermatitis: meta-analysis of randomised controlled trials. BMJ 2005;330:516 «PMID: 15731121»PubMed
  6. Autio P, Komulainen P, Larni HM. Heliotherapy in atopic dermatitis: a prospective study on climatotherapy using the SCORAD index. Acta Derm Venereol 2002;82:436-40 «PMID: 12575850»PubMed
  7. Bath-Hextall FJ, Jenkinson C, Humphreys R ym. Dietary supplements for established atopic eczema. Cochrane Database Syst Rev 2012;:CD005205 «PMID: 22336810»PubMed
  8. Berth-Jones J, Damstra RJ, Golsch S ym. Twice weekly fluticasone propionate added to emollient maintenance treatment to reduce risk of relapse in atopic dermatitis: randomised, double blind, parallel group study. BMJ 2003;326:1367 «PMID: 12816824»PubMed
  9. Berth-Jones J, Takwale A, Tan E ym. Azathioprine in severe adult atopic dermatitis: a double-blind, placebo-controlled, crossover trial. Br J Dermatol 2002;147:324-30 «PMID: 12174106»PubMed
  10. Bieber T, Simpson EL, Silverberg JI ym. Abrocitinib versus Placebo or Dupilumab for Atopic Dermatitis. N Engl J Med 2021;384:1101-1112 «PMID: 33761207»PubMed
  11. Bjerre RD, Bandier J, Skov L ym. The role of the skin microbiome in atopic dermatitis: a systematic review. Br J Dermatol 2017;177:1272-1278 «PMID: 28207943»PubMed
  12. Blauvelt A, de Bruin-Weller M, Gooderham M ym. Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial. Lancet 2017;389:2287-2303 «PMID: 28478972»PubMed
  13. Bohle B. The impact of pollen-related food allergens on pollen allergy. Allergy 2007;62:3-10 «PMID: 17156335»PubMed
  14. Breneman D, Fleischer AB Jr, Abramovits W ym. Intermittent therapy for flare prevention and long-term disease control in stabilized atopic dermatitis: a randomized comparison of 3-times-weekly applications of tacrolimus ointment versus vehicle. J Am Acad Dermatol 2008;58:990-9 «PMID: 18359127»PubMed
  15. Breuer K, HAussler S, Kapp A ym. Staphylococcus aureus: colonizing features and influence of an antibacterial treatment in adults with atopic dermatitis. Br J Dermatol 2002;147:55-61 «PMID: 12100185»PubMed
  16. Chapman MS, Schachner LA, Breneman D ym. Tacrolimus ointment 0.03% shows efficacy and safety in pediatric and adult patients with mild to moderate atopic dermatitis. J Am Acad Dermatol 2005;53:S177-85 «PMID: 16021173»PubMed
  17. Chiang C, Eichenfield LF. Quantitative assessment of combination bathing and moisturizing regimens on skin hydration in atopic dermatitis. Pediatr Dermatol 2009;26:273-8 «PMID: 19706087»PubMed
  18. Chida Y, Steptoe A, Hirakawa N ym. The effects of psychological intervention on atopic dermatitis. A systematic review and meta-analysis. Int Arch Allergy Immunol 2007;144:1-9 «PMID: 17449959»PubMed
  19. Chinn DJ, Poyner T, Sibley G. Randomized controlled trial of a single dermatology nurse consultation in primary care on the quality of life of children with atopic eczema. Br J Dermatol 2002;146:432-9 «PMID: 11952543»PubMed
  20. Cork MJ, Britton J, Butler L ym. Comparison of parent knowledge, therapy utilization and severity of atopic eczema before and after explanation and demonstration of topical therapies by a specialist dermatology nurse. Br J Dermatol 2003;149:582-9 «PMID: 14510993»PubMed
  21. Cury Martins J, Martins C, Aoki V ym. Topical tacrolimus for atopic dermatitis. Cochrane Database Syst Rev 2015;2015:CD009864 «PMID: 26132597»PubMed
  22. de Bruin-Weller M, Thaçi D, Smith CH ym. Dupilumab with concomitant topical corticosteroid treatment in adults with atopic dermatitis with an inadequate response or intolerance to ciclosporin A or when this treatment is medically inadvisable: a placebo-controlled, randomized phase III clinical trial (LIBERTY AD CAFÉ). Br J Dermatol 2018;178:1083-1101 «PMID: 29193016»PubMed
  23. Der-Petrossian M, Seeber A, Hönigsmann H ym. Half-side comparison study on the efficacy of 8-methoxypsoralen bath-PUVA versus narrow-band ultraviolet B phototherapy in patients with severe chronic atopic dermatitis. Br J Dermatol 2000;142:39-43 «PMID: 10651692»PubMed
  24. Doss N, Kamoun MR, Dubertret L ym. Efficacy of tacrolimus 0.03% ointment as second-line treatment for children with moderate-to-severe atopic dermatitis: evidence from a randomized, double-blind non-inferiority trial vs. fluticasone 0.005% ointment. Pediatr Allergy Immunol 2010;21:321-9 «PMID: 19563466»PubMed
  25. Draelos Z, Nayak A, Pariser D ym. Pharmacokinetics of topical calcineurin inhibitors in adult atopic dermatitis: a randomized, investigator-blind comparison. J Am Acad Dermatol 2005;53:602-9 «PMID: 16198779»PubMed
  26. Eichenfield LF, Lucky AW, Boguniewicz M ym. Safety and efficacy of pimecrolimus (ASM 981) cream 1% in the treatment of mild and moderate atopic dermatitis in children and adolescents. J Am Acad Dermatol 2002;46:495-504 «PMID: 11907497»PubMed
  27. Ersser SJ, Cowdell F, Latter S ym. Psychological and educational interventions for atopic eczema in children. Cochrane Database Syst Rev 2014;2014:CD004054 «PMID: 24399641»PubMed
  28. Fleischer AB Jr, Abramovits W, Breneman D ym. Tacrolimus ointment is more effective than pimecrolimus cream in adult patients with moderate to very severe atopic dermatitis. J Dermatolog Treat 2007;18:151-7 «PMID: 17538803»PubMed
  29. Garritsen FM, Brouwer MW, Limpens J ym. Photo(chemo)therapy in the management of atopic dermatitis: an updated systematic review with implications for practice and research. Br J Dermatol 2014;170:501-13 «PMID: 24116934»PubMed
  30. George SA, Bilsland DJ, Johnson BE ym. Narrow-band (TL-01) UVB air-conditioned phototherapy for chronic severe adult atopic dermatitis. Br J Dermatol 1993;128:49-56 «PMID: 8427822»PubMed
  31. Gerbens LAA, Hamann SAS, Brouwer MWD ym. Methotrexate and azathioprine for severe atopic dermatitis: a 5-year follow-up study of a randomized controlled trial. Br J Dermatol 2018;178:1288-1296 «PMID: 29237228»PubMed
  32. Gollnick H, Kaufmann R, Stough D ym. Pimecrolimus cream 1% in the long-term management of adult atopic dermatitis: prevention of flare progression. A randomized controlled trial. Br J Dermatol 2008;158:1083-93 «PMID: 18341665»PubMed
  33. Goujon C, Viguier M, Staumont-Sallé D ym. Methotrexate Versus Cyclosporine in Adults with Moderate-to-Severe Atopic Dermatitis: A Phase III Randomized Noninferiority Trial. J Allergy Clin Immunol Pract 2018;6:562-569.e3 «PMID: 28967549»PubMed
  34. Grundmann-Kollmann M, Behrens S, Podda M ym. Phototherapy for atopic eczema with narrow-band UVB. J Am Acad Dermatol 1999;40:995-7 «PMID: 10365933»PubMed
  35. Guttman-Yassky E, Teixeira HD, Simpson EL ym. Once-daily upadacitinib versus placebo in adolescents and adults with moderate-to-severe atopic dermatitis (Measure Up 1 and Measure Up 2): results from two replicate double-blind, randomised controlled phase 3 trials. Lancet 2021;397:2151-2168 «PMID: 34023008»PubMed
  36. Haeck IM, Knol MJ, Ten Berge O ym. Enteric-coated mycophenolate sodium versus cyclosporin A as long-term treatment in adult patients with severe atopic dermatitis: a randomized controlled trial. J Am Acad Dermatol 2011;64:1074-84 «PMID: 21458107»PubMed
  37. Hanifin JM, Ling MR, Langley R ym. Tacrolimus ointment for the treatment of atopic dermatitis in adult patients: part I, efficacy. J Am Acad Dermatol 2001;44:S28-38 «PMID: 11145793»PubMed
  38. Harari M, Shani J, Seidl V ym. Climatotherapy of atopic dermatitis at the Dead Sea: demographic evaluation and cost-effectiveness. Int J Dermatol 2000;39:59-69 «PMID: 10651969»PubMed
  39. Hjerppe M, Hasan T, Saksala I ym. Narrow-band UVB treatment in atopic dermatitis. Acta Derm Venereol 2001;81:439-40 «PMID: 11859955»PubMed
  40. Ho VC, Gupta A, Kaufmann R ym. Safety and efficacy of nonsteroid pimecrolimus cream 1% in the treatment of atopic dermatitis in infants. J Pediatr 2003;142:155-62 «PMID: 12584537»PubMed
  41. Hoeger PH, Lee KH, Jautova J ym. The treatment of facial atopic dermatitis in children who are intolerant of, or dependent on, topical corticosteroids: a randomized, controlled clinical trial. Br J Dermatol 2009;160:415-22 «PMID: 19067708»PubMed
  42. Hoeger PH, Lenz W, Boutonnier A ym. Staphylococcal skin colonization in children with atopic dermatitis: prevalence, persistence, and transmission of toxigenic and nontoxigenic strains. J Infect Dis 1992;165:1064-8 «PMID: 1583324»PubMed
  43. Hua T, Yousaf M, Gwillim E ym. Does daily bathing or showering worsen atopic dermatitis severity? A systematic review and meta-analysis. Arch Dermatol Res 2021;313:729-735 «PMID: 33196889»PubMed
  44. Jiang W, Ni B, Liu Z ym. The Role of Probiotics in the Prevention and Treatment of Atopic Dermatitis in Children: An Updated Systematic Review and Meta-Analysis of Randomized Controlled Trials. Paediatr Drugs 2020;22:535-549 «PMID: 32748341»PubMed
  45. Kalliomäki M, Salminen S, Arvilommi H ym. Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial. Lancet 2001;357:1076-9 «PMID: 11297958»PubMed
  46. Kalliomäki M, Salminen S, Poussa T ym. Probiotics and prevention of atopic disease: 4-year follow-up of a randomised placebo-controlled trial. Lancet 2003;361:1869-71 «PMID: 12788576»PubMed
  47. Kalliomäki M, Salminen S, Poussa T ym. Probiotics during the first 7 years of life: a cumulative risk reduction of eczema in a randomized, placebo-controlled trial. J Allergy Clin Immunol 2007;119:1019-21 «PMID: 17289135»PubMed
  48. Kapp A, Papp K, Bingham A ym. Long-term management of atopic dermatitis in infants with topical pimecrolimus, a nonsteroid anti-inflammatory drug. J Allergy Clin Immunol 2002;110:277-84 «PMID: 12170269»PubMed
  49. Karppinen TT, Ylianttila L, Kautiainen H ym. Empowering heliotherapy improves clinical outcome and quality of life of psoriasis and atopic dermatitis patients. Acta Derm Venereol 2015;95:579-82 «PMID: 25474161»PubMed
  50. Kaufmann R, Bieber T, Helgesen AL ym. Onset of pruritus relief with pimecrolimus cream 1% in adult patients with atopic dermatitis: a randomized trial. Allergy 2006;61:375-81 «PMID: 16436149»PubMed
  51. Kaufmann R, Fölster-Holst R, Höger P ym. Onset of action of pimecrolimus cream 1% in the treatment of atopic eczema in infants. J Allergy Clin Immunol 2004;114:1183-8 «PMID: 15536429»PubMed
  52. Kong HH, Oh J, Deming C ym. Temporal shifts in the skin microbiome associated with disease flares and treatment in children with atopic dermatitis. Genome Res 2012;22:850-9 «PMID: 22310478»PubMed
  53. Kritsanaviparkporn C, Sangaphunchai P, Treesirichod A. Efficacy of moisturizers in paediatric atopic dermatitis: A systematic review and meta-analysis of randomised controlled trials. Indian J Dermatol Venereol Leprol 2021;88:22-31 «PMID: 34623061»PubMed
  54. Kuitunen M, Kukkonen K, Juntunen-Backman K ym. Probiotics prevent IgE-associated allergy until age 5 years in cesarean-delivered children but not in the total cohort. J Allergy Clin Immunol 2009;123:335-41 «PMID: 19135235»PubMed
  55. Kukkonen K, Savilahti E, Haahtela T ym. Probiotics and prebiotic galacto-oligosaccharides in the prevention of allergic diseases: a randomized, double-blind, placebo-controlled trial. J Allergy Clin Immunol 2007;119:192-8 «PMID: 17208601»PubMed
  56. Li L, Han Z, Niu X ym. Probiotic Supplementation for Prevention of Atopic Dermatitis in Infants and Children: A Systematic Review and Meta-analysis. Am J Clin Dermatol 2019;20:367-377 «PMID: 30465329»PubMed
  57. Lindh JD, Bradley M. Clinical Effectiveness of Moisturizers in Atopic Dermatitis and Related Disorders: A Systematic Review. Am J Clin Dermatol 2015;16:341-59 «PMID: 26267423»PubMed
  58. Luger T, Van Leent EJ, Graeber M ym. SDZ ASM 981: an emerging safe and effective treatment for atopic dermatitis. Br J Dermatol 2001;144:788-94 «PMID: 11298538»PubMed
  59. Matterne U, Böhmer MM, Weisshaar E ym. Oral H1 antihistamines as 'add-on' therapy to topical treatment for eczema. Cochrane Database Syst Rev 2019;1:CD012167 «PMID: 30666626»PubMed
  60. Meggitt SJ, Gray JC, Reynolds NJ. Azathioprine dosed by thiopurine methyltransferase activity for moderate-to-severe atopic eczema: a double-blind, randomised controlled trial. Lancet 2006;367:839-46 «PMID: 16530578»PubMed
  61. Meher BR, Mohanty RR, Padhy BM. Efficacy and safety of abrocitinib for the treatment of moderate-to-severe atopic dermatitis: a meta-analysis of randomized clinical trials. J Dermatolog Treat 2022;33:2335-2343 «PMID: 34315323»PubMed
  62. Murrell DF, Calvieri S, Ortonne JP ym. A randomized controlled trial of pimecrolimus cream 1% in adolescents and adults with head and neck atopic dermatitis and intolerant of, or dependent on, topical corticosteroids. Br J Dermatol 2007;157:954-9 «PMID: 17935515»PubMed
  63. Paller AS, Eichenfield LF, Kirsner RS ym. Three times weekly tacrolimus ointment reduces relapse in stabilized atopic dermatitis: a new paradigm for use. Pediatrics 2008;122:e1210-8 «PMID: 19015204»PubMed
  64. Paller AS, Lebwohl M, Fleischer AB Jr ym. Tacrolimus ointment is more effective than pimecrolimus cream with a similar safety profile in the treatment of atopic dermatitis: results from 3 randomized, comparative studies. J Am Acad Dermatol 2005;52:810-22 «PMID: 15858471»PubMed
  65. Paller AS, Siegfried EC, Thaçi D ym. Efficacy and safety of dupilumab with concomitant topical corticosteroids in children 6 to 11 years old with severe atopic dermatitis: A randomized, double-blinded, placebo-controlled phase 3 trial. J Am Acad Dermatol 2020;83:1282-1293 «PMID: 32574587»PubMed
  66. Peldan P, Kukkonen AK, Savilahti E ym. Perinatal probiotics decreased eczema up to 10 years of age, but at 5-10 years, allergic rhino-conjunctivitis was increased. Clin Exp Allergy 2017;47:975-979 «PMID: 28316095»PubMed
  67. Peserico A, Städtler G, Sebastian M ym. Reduction of relapses of atopic dermatitis with methylprednisolone aceponate cream twice weekly in addition to maintenance treatment with emollient: a multicentre, randomized, double-blind, controlled study. Br J Dermatol 2008;158:801-7 «PMID: 18284403»PubMed
  68. Rautava S, Kainonen E, Salminen S ym. Maternal probiotic supplementation during pregnancy and breast-feeding reduces the risk of eczema in the infant. J Allergy Clin Immunol 2012;130:1355-60 «PMID: 23083673»PubMed
  69. Reich K, Kabashima K, Peris K ym. Efficacy and Safety of Baricitinib Combined With Topical Corticosteroids for Treatment of Moderate to Severe Atopic Dermatitis: A Randomized Clinical Trial. JAMA Dermatol 2020;156:1333-1343 «PMID: 33001140»PubMed
  70. Reich K, Teixeira HD, de Bruin-Weller M ym. Safety and efficacy of upadacitinib in combination with topical corticosteroids in adolescents and adults with moderate-to-severe atopic dermatitis (AD Up): results from a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet 2021;397:2169-2181 «PMID: 34023009»PubMed
  71. Reitamo S, Harper J, Bos JD ym. 0.03% Tacrolimus ointment applied once or twice daily is more efficacious than 1% hydrocortisone acetate in children with moderate to severe atopic dermatitis: results of a randomized double-blind controlled trial. Br J Dermatol 2004;150:554-62 «PMID: 15030341»PubMed
  72. Reitamo S, Ortonne JP, Sand C ym. A multicentre, randomized, double-blind, controlled study of long-term treatment with 0.1% tacrolimus ointment in adults with moderate to severe atopic dermatitis. Br J Dermatol 2005;152:1282-9 «PMID: 15948994»PubMed
  73. Reitamo S, Rustin M, Ruzicka T ym. Efficacy and safety of tacrolimus ointment compared with that of hydrocortisone butyrate ointment in adult patients with atopic dermatitis. J Allergy Clin Immunol 2002;109:547-55 «PMID: 11898005»PubMed
  74. Reitamo S, Van Leent EJ, Ho V ym. Efficacy and safety of tacrolimus ointment compared with that of hydrocortisone acetate ointment in children with atopic dermatitis. J Allergy Clin Immunol 2002;109:539-46 «PMID: 11898004»PubMed
  75. Reynolds NJ, Franklin V, Gray JC ym. Narrow-band ultraviolet B and broad-band ultraviolet A phototherapy in adult atopic eczema: a randomised controlled trial. Lancet 2001;357:2012-6 «PMID: 11438134»PubMed
  76. Ridd MJ, King AJL, Le Roux E ym. Systematic review of self-management interventions for people with eczema. Br J Dermatol 2017;177:719-734 «PMID: 28432696»PubMed
  77. Roekevisch E, Schram ME, Leeflang MMG ym. Methotrexate versus azathioprine in patients with atopic dermatitis: 2-year follow-up data. J Allergy Clin Immunol 2018;141:825-827.e10 «PMID: 29111215»PubMed
  78. Schmitt J, von Kobyletzki L, Svensson A ym. Efficacy and tolerability of proactive treatment with topical corticosteroids and calcineurin inhibitors for atopic eczema: systematic review and meta-analysis of randomized controlled trials. Br J Dermatol 2011;164:415-28 «PMID: 20819086»PubMed
  79. Schneider L, Hanifin J, Boguniewicz M ym. Study of the Atopic March: Development of Atopic Comorbidities. Pediatr Dermatol 2016;33:388-98 «PMID: 27273433»PubMed
  80. Schram ME, Roekevisch E, Leeflang MM ym. A randomized trial of methotrexate versus azathioprine for severe atopic eczema. J Allergy Clin Immunol 2011;128:353-9 «PMID: 21514637»PubMed
  81. Siegels D, Heratizadeh A, Abraham S ym. Systemic treatments in the management of atopic dermatitis: A systematic review and meta-analysis. Allergy 2021;76:1053-1076 «PMID: 33074565»PubMed
  82. Siegfried E, Korman N, Molina C ym. Safety and efficacy of early intervention with pimecrolimus cream 1% combined with corticosteroids for major flares in infants and children with atopic dermatitis. J Dermatolog Treat 2006;17:143-50 «PMID: 16854753»PubMed
  83. Silverberg JI, Simpson EL, Thyssen JP ym. Efficacy and Safety of Abrocitinib in Patients With Moderate-to-Severe Atopic Dermatitis: A Randomized Clinical Trial. JAMA Dermatol 2020;156:863-873 «PMID: 32492087»PubMed
  84. Simpson E, Trookman NS, Rizer RL ym. Safety and tolerability of a body wash and moisturizer when applied to infants and toddlers with a history of atopic dermatitis: results from an open-label study. Pediatr Dermatol 2012;29:590-7 «PMID: 22775151»PubMed
  85. Simpson EL, Bieber T, Guttman-Yassky E ym. Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis. N Engl J Med 2016;375:2335-2348 «PMID: 27690741»PubMed
  86. Simpson EL, Lacour JP, Spelman L ym. Baricitinib in patients with moderate-to-severe atopic dermatitis and inadequate response to topical corticosteroids: results from two randomized monotherapy phase III trials. Br J Dermatol 2020;183:242-255 «PMID: 31995838»PubMed
  87. Simpson EL, Sinclair R, Forman S ym. Efficacy and safety of abrocitinib in adults and adolescents with moderate-to-severe atopic dermatitis (JADE MONO-1): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial. Lancet 2020;396:255-266 «PMID: 32711801»PubMed
  88. Soter NA, Fleischer AB Jr, Webster GF ym. Tacrolimus ointment for the treatment of atopic dermatitis in adult patients: part II, safety. J Am Acad Dermatol 2001;44:S39-46 «PMID: 11145794»PubMed
  89. Staab D, Diepgen TL, Fartasch M ym. Age related, structured educational programmes for the management of atopic dermatitis in children and adolescents: multicentre, randomised controlled trial. BMJ 2006;332:933-8 «PMID: 16627509»PubMed
  90. Takwale A, Tan E, Agarwal S ym. Efficacy and tolerability of borage oil in adults and children with atopic eczema: randomised, double blind, placebo controlled, parallel group trial. BMJ 2003;327:1385 «PMID: 14670885»PubMed
  91. Thaci D, Chambers C, Sidhu M ym. Twice-weekly treatment with tacrolimus 0.03% ointment in children with atopic dermatitis: clinical efficacy and economic impact over 12 months. J Eur Acad Dermatol Venereol 2010;24:1040-6 «PMID: 20158589»PubMed
  92. Thaçi D, Reitamo S, Gonzalez Ensenat MA ym. Proactive disease management with 0.03% tacrolimus ointment for children with atopic dermatitis: results of a randomized, multicentre, comparative study. Br J Dermatol 2008;159:1348-56 «PMID: 18782319»PubMed
  93. Totté JE, van der Feltz WT, Hennekam M ym. Prevalence and odds of Staphylococcus aureus carriage in atopic dermatitis: a systematic review and meta-analysis. Br J Dermatol 2016;175:687-95 «PMID: 26994362»PubMed
  94. Uehara M, Takada K. Use of soap in the management of atopic dermatitis. Clin Exp Dermatol 1985;10:419-25 «PMID: 4075572»PubMed
  95. Van Der Meer JB, Glazenburg EJ, Mulder PG ym. The management of moderate to severe atopic dermatitis in adults with topical fluticasone propionate. The Netherlands Adult Atopic DermatitisStudy Group. Br J Dermatol 1999;140:1114-21 «PMID: 10354080»PubMed
  96. van Gool CJ, Zeegers MP, Thijs C. Oral essential fatty acid supplementation in atopic dermatitis-a meta-analysis of placebo-controlled trials. Br J Dermatol 2004;150:728-40 «PMID: 15099370»PubMed
  97. van Zuuren EJ, Fedorowicz Z, Christensen R ym. Emollients and moisturisers for eczema. Cochrane Database Syst Rev 2017;2:CD012119 «PMID: 28166390»PubMed
  98. Wahn U, Bos JD, Goodfield M ym. Efficacy and safety of pimecrolimus cream in the long-term management of atopic dermatitis in children. Pediatrics 2002;110:e2 «PMID: 12093983»PubMed
  99. Wassmann-Otto A, Heratizadeh A, Wichmann K ym. Birch pollen-related foods can cause late eczematous reactions in patients with atopic dermatitis. Allergy 2018;73:2046-2054 «PMID: 29654628»PubMed
  100. White MI, Jenkinson DM, Lloyd DH. The effect of washing on the thickness of the stratum corneum in normal and atopic individuals. Br J Dermatol 1987;116:525-30 «PMID: 3580287»PubMed
  101. Wickens K, Barthow C, Mitchell EA ym. Maternal supplementation alone with Lactobacillus rhamnosus HN001 during pregnancy and breastfeeding does not reduce infant eczema. Pediatr Allergy Immunol 2018;29:296-302 «PMID: 29415330»PubMed
  102. Wickens K, Black P, Stanley TV ym. A protective effect of Lactobacillus rhamnosus HN001 against eczema in the first 2 years of life persists to age 4 years. Clin Exp Allergy 2012;42:1071-9 «PMID: 22702506»PubMed
  103. Wickens K, Black PN, Stanley TV ym. A differential effect of 2 probiotics in the prevention of eczema and atopy: a double-blind, randomized, placebo-controlled trial. J Allergy Clin Immunol 2008;122:788-794 «PMID: 18762327»PubMed
  104. Wickens K, Stanley TV, Mitchell EA ym. Early supplementation with Lactobacillus rhamnosus HN001 reduces eczema prevalence to 6 years: does it also reduce atopic sensitization? Clin Exp Allergy 2013;43:1048-57 «PMID: 23957340»PubMed
  105. Williams JV, Vowels BR, Honig PJ ym. S. aureus isolation from the lesions, the hands, and the anterior nares of patients with atopic dermatitis. Pediatr Dermatol 1998;15:194-8 «PMID: 9655314»PubMed
  106. Wollenberg A, Nakahara T, Maari C ym. Impact of baricitinib in combination with topical steroids on atopic dermatitis symptoms, quality of life and functioning in adult patients with moderate-to-severe atopic dermatitis from the BREEZE-AD7 Phase 3 randomized trial. J Eur Acad Dermatol Venereol 2021;35:1543-1552 «PMID: 33834521»PubMed
  107. Wollenberg A, Reitamo S, Girolomoni G ym. Proactive treatment of atopic dermatitis in adults with 0.1% tacrolimus ointment. Allergy 2008;63:742-50 «PMID: 18592619»PubMed
  108. Worm M, Forschner K, Lee HH ym. Frequency of atopic dermatitis and relevance of food allergy in adults in Germany. Acta Derm Venereol 2006;86:119-22 «PMID: 16648913»PubMed
  109. Yan J, Chen SL, Wang XL ym. Meta-analysis of tacrolimus ointment for atopic dermatitis in pediatric patients. Pediatr Dermatol 2008;25:117-20 «PMID: 18304172»PubMed
  110. Zuberbier T, Bräutigam M. Long-term management of facial atopic eczema with pimecrolimus cream 1% in paediatric patients with mild to moderate disease. J Eur Acad Dermatol Venereol 2008;22:718-21 «PMID: 18312323»PubMed